EPA Omega-3 and Brain Health: A Critical Review of What the Evidence Really Shows

This review takes a close look at eicosapentaenoic acid (EPA), one of the two main omega-3 fatty acids, and its possible role in emotional well-being and brain aging. The authors specifically separate studies that tested EPA on its own from studies that looked at mixed omega-3 supplements, fish intake, or blood omega-3 levels, since these are often lumped together in a way that can be misleading.

They found that evidence involving EPA specifically is most developed for depressive symptoms, while research on brain aging and brain imaging outcomes mostly comes from studies on fish consumption or general omega-3 status rather than EPA given as a standalone intervention. The review treats this brain-aging evidence as an interesting starting point for future research rather than proof of an EPA-specific effect.

The paper also proposes a research framework suggesting EPA might influence the brain indirectly, through its role in resolving inflammation in the body, supporting blood vessel function, and affecting the blood-brain barrier and immune-brain communication. It highlights how differences in EPA dose, EPA-to-DHA ratio, formulation, study duration, baseline inflammation, and other factors make it hard to compare studies directly.